🔗 Permalink

Inventor profile of:

Andreas Loew

City:

Cambridge, Massachusetts

Country:

United States

Published Applications:

Last publication date:

2022-08-04

Top Assignees for applications by Andreas Loew

The entities that hold a legal rights for patent applications filed by inventor Loew Andreas:

NOVARTIS AG 16 Basel, Switzerland
THE TRUSTEES OF THE UNIVERSITY OF PENNSYLVANIA 12 PHILADELPHIA, PA United States
UNIVERSITY OF PITTSBURGH-OF THE COMMONWEALTH SYSTEM OF HIGHER EDUCATION 2 Pittsburgh, PA United States
Marengo Therapeutics, Inc. 2 Cambridge, MA United States

Recent patent applications by Loew Andreas

Andreas Loew from Cambridge, US has applied for patents for these inventions. The list has both pending applications and granted patents:

#1 | 2022-08-04

US20220242957A1

Chemistry; metallurgy

CSF1R/CCR2 MULTISPECIFIC ANTIBODIES

#2 | 2021-09-09

US20210277119A1

Chemistry; metallurgy

Anti-TCR antibody molecules and uses thereof

#3 | 2021-05-13

US20210137982A1

Human necessities

Calreticulin binding constructs and engineered T cells for the treatment of diseases

#4 | 2017-11-23

US20170335281A1

Chemistry; metallurgy

TREATMENT OF CANCER USING CHIMERIC ANTIGEN RECEPTOR

#5 | 2017-07-27

US20170211055A1

Chemistry; metallurgy

Sortase synthesized chimeric antigen receptors

#6 | 2017-06-29

US20170183415A1

Chemistry; metallurgy

Effective targeting of primary human leukemia using anti-CD123 chimeric antigen receptor engineered T cells

#7 | 2017-03-23

US20170081411A1

Chemistry; metallurgy

REGULATABLE CHIMERIC ANTIGEN RECEPTOR

#8 | 2017-01-12

US20170008963A1

Chemistry; metallurgy

Treatment of cancer using humanized anti-EGFRvIII chimeric antigen receptor

#9 | 2016-12-29

US20160376345A1

Chemistry; metallurgy

FIBRONECTIN-BASED BINDING MOLECULES AND USES THEREOF

#10 | 2016-12-15

US20160362472A1

Chemistry; metallurgy

CD20 therapies, CD22 therapies, and combination therapies with a CD19 chimeric antigen receptor (CAR)-expressing cell

#11 | 2016-10-27

US20160311917A1

Chemistry; metallurgy

Human mesothelin chimeric antigen receptors and uses thereof

#12 | 2016-10-27

US20160311907A1

Chemistry; metallurgy

Regulatable chimeric antigen receptor

#13 | 2016-07-07

US20160194626A1

Chemistry; metallurgy

Universal fibronectin type III bottom-side binding domain libraries

#14 | 2016-03-10

US20160068601A1

Chemistry; metallurgy

Treatment of cancer using a CD123 chimeric antigen receptor

#15 | 2014-10-30

US20140322275A1

Chemistry; metallurgy

Treatment of cancer using humanized anti-EGFRvIII chimeric antigen receptor

#16 | 2014-10-30

US20140322212A1

Chemistry; metallurgy

Effective targeting of primary human leukemia using anti-CD123 chimeric antigen receptor engineered T cells

#17 | 2014-09-18

US20140271635A1

Chemistry; metallurgy

Treatment of cancer using humanized anti-CD19 chimeric antigen receptor

#18 | 2011-11-10

US20110275535A1

Chemistry; metallurgy

Yeast Display Systems

#19 | 2011-02-17

US20110038866A1

Chemistry; metallurgy

Fibronectin-based binding molecules and uses thereof

InventorID:

952712 ⎘